Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] SK Hynix (000660) – New Facility Investment / 2026-07-22

Posted on July 22, 2026July 29, 2026 By K-STOCK Editor No Comments on [Disclosure] SK Hynix (000660) – New Facility Investment / 2026-07-22

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

SK Hynix has decided to invest a total of KRW 7.09T in the construction of Cheongju P&T7 to secure a production base responding to global AI memory demand.

📊 [Key Summary & Financial Figures]

  • Company Name: SK Hynix Inc.
  • Stock Code: 000660
  • Investment Type: New Facility Investment
  • Investment Target: Cheongju P&T7 Construction
  • Investment Amount: KRW 7,093,100,000,000 (KRW 7.09T)
  • Equity: KRW 120,666,750,890,698 (Based on consolidated financial statements at the end of the most recent fiscal year)
  • Investment to Equity Ratio: 5.88%
  • Large-scale Corporation: Yes
  • Purpose of Investment: Securing a production base in Cheongju to meet global AI memory demand
  • Investment Period: November 26, 2025 ~ December 31, 2032
  • Board Resolution Date: July 22, 2026 (6 outside directors present, 0 absent)
  • Other Key Decision Details:
    • This investment pertains to Cheongju P&T7 Fab construction; the board resolved at the 8th meeting of 2026 (2026.07.22) to increase the investment amount due to production expansion and shortening the Clean Room opening schedule.
    • The investment amount and end date may change based on investment progress and changes in the management environment.
    • Start date (2025-11-26) is based on the initiation date of Cheongju P&T7 construction investment.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verifying Progress and Actual Execution of Facility Investment

This disclosure announces an increase in the investment amount to KRW 7.09T for the Cheongju P&T7 Fab construction due to production expansion and an accelerated timeline. Tracking the execution progress of investment funds and compliance with the scheduled timeline is important to understand how large-scale facility investments are reflected in actual financial conditions and operations. Relevant details and progress can be verified through subsequent periodic reports and related disclosures.

📢 Disclaimer and Source Notice

Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s DART system.

Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Hanmi Semiconductor (042700) – Corporate Value-up Plan (Voluntary Disclosure) / 2026-07-20
Next Post: [Disclosure] SK Hynix (000660) – Clarification Regarding Rumors or Reports / 2026-07-22

Related Posts

[Disclosure] Samsung Biologics (207940) – Decision on Acquisition of Shares and Equity Securities of Other Corporations (Voluntary Disclosure) / 2025-12-22 Disclosures
[Disclosure] Celltrion (068270) – Rulings on Lawsuit (Correction) / 2025-07-11 Disclosures
[Disclosure] Celltrion (068270) – Provisional Sales Results (Consolidated Financial Statements) / 2024-05-09 Bio & Healthcare
[Disclosure] Hana Micron (067310) – Additional Listing (Exercise of Stock Options) / 2026-01-26 Semiconductors
[Disclosure] SK Hynix (000660) – Decision on Disposal of Treasury Shares / 2026-05-13 Semiconductors
[Disclosure] Daeduck Electronics (353200) – New Facility Investment / 2026-05-11 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme